Results 221 to 230 of about 19,341 (309)
Optimizing multi-level shuttle-based puzzle storage systems with horizontal and vertical dynamics using integer programming and ALNS-IP. [PDF]
Al Jneid R, Yiğit V, Keskin ME.
europepmc +1 more source
MDM2 dependency in pediatric sarcomas is driven by a novel p53‐independent oncogenic cistrome alongside canonical p53 pathway suppression. This study introduces MDM2‐recruiting transcriptional and epigenetic machinery degraders (MDM2‐TEMADs) as a novel precision oncology modality.
Jiawei Zhou +21 more
wiley +1 more source
A Contrastive Dual-Task Framework for Few-Shot Traffic Classification in IoT Networks. [PDF]
Lu Z, Chen M, Cui S, Zhao B, Zheng Y.
europepmc +1 more source
Modeling and Enhancement for Voice over IP-Networks
博士学位論文 (Thesis(doctor)) 2188881 ...
openaire
mGluR5 in ECCCK to BLA Circuit Modulates Depressive‐Like Phenotypes through CCK Signaling
Dysregulation of mGluR5 and CCK signaling contributes to major depressive disorder, yet circuit‐level mechanisms remain unclear. Here, the ECCCK→BLA pathway is identified as a critical regulator of affective behavior. mGluR5 modulates synaptic function and CCK signaling within this circuit, controlling stress susceptibility and depressive‐like states ...
Muhammad Asim +4 more
wiley +1 more source
A Brief Progress in Methods for Deciphering Protein-Protein Interaction Networks. [PDF]
Yang X, Cui W, Wang L, Zheng Y.
europepmc +1 more source
Bone cancer pain and depression share a common origin: astrocytic A2‐to‐A1 transition in the posterior piriform cortex. This phenotypic shift disrupts the ATP–adenosine–A2AR–norepinephrine axis, simultaneously driving nociceptive and affective dysfunction.
Jiang‐Ping Liu +14 more
wiley +1 more source
Post-transcriptional regulatory networks: The dynamic interplay of RNA-binding proteins. [PDF]
Street LA, Jovanovic M, Fornasiero EF.
europepmc +1 more source
A multifunctional nanoagonist (cDZ@IP) enables nano‐metabolite–driven multimodal activation of the STING pathway and enhanced immune recognition, achieving potent antitumor immunity and suppressing tumor growth and metastasis. This strategy highlights the rational design of therapeutic metabolites and establishes a new paradigm bridging nanomedicine ...
Kepeng Hu +17 more
wiley +1 more source

